Abstract |
Ataxia-telangiectasia is a syndrome with many facets, involving a progressive cerebellar ataxia, immunodeficiency, cancer susceptibility, radiosensitivity, defects in DNA repair/processing, chromosomal breakage and rearrangements, elevated serum alphafetoprotein, and premature aging. Ataxia-telangiectasia is an autosomal recessive disorder, rare in outbred populations; carriers of the ataxia-telangiectasia gene may be as common as 1 in 60 and have subclinical radiosensitivity and cancer susceptibility. One estimate suggests that 8.8% of patients with breast cancer could be carriers of ataxia-telangiectasia. These carriers may be responsible for underestimating normal tolerance doses for radiation therapy by 15% to 20%; thus by preselecting and excluding carriers of ataxia-telangiectasia from cohorts of patients with cancer, conventional radiation doses might be increased so as to improve greatly the efficacy of radiotherapy. The genes for the 3 most common ataxia-telangiectasia complementation groups, which include 97% of tested families, have recently been localized to the long arm of chromosome 11.
|
Authors | R A Gatti, E Boder, H V Vinters, R S Sparkes, A Norman, K Lange |
Journal | Medicine
(Medicine (Baltimore))
Vol. 70
Issue 2
Pg. 99-117
(Mar 1991)
ISSN: 0025-7974 [Print] United States |
PMID | 2005780
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review)
|
Topics |
- Ataxia Telangiectasia
(diagnosis, genetics, pathology)
- Brain
(pathology)
- Chromosome Mapping
- Genetic Linkage
- Humans
- Radiation Tolerance
|